About Careers Internship MedBlog Contact us

3D Organoids from Tumors of Cancer Patients May Help Develop Improved Treatments

by Bidita Debnath on May 9, 2015 at 1:58 AM
3D Organoids from Tumors of Cancer Patients May Help Develop Improved Treatments

Scientists have derived a collection of 3D cultures or "organoids" from tumors of cancer patients that closely replicate key properties of the original tumors.

These "organoid" cultures or a living "biobank" can help detect genetic changes associated with drug sensitivity and pave the way for personalized cancer treatment.


"We believe that these organoids are an important new tool in the arsenal of cancer biologists and may ultimately improve our ability to develop more effective cancer treatments," explained senior study author Mathew Garnett, geneticist at the Wellcome Trust Sanger Institute, a non-profit organization situated outside Cambridge.

In recent years, scientists have developed organoid cell culture systems as an alternative approach to grow normal and diseased tissue in a dish.

In contrast to cell lines, organoids display the hallmarks of the original tissue in terms of its 3D architecture, the cell types present and their self-renewal properties.

In the new study, the researchers grew 22 organoids derived from tumor tissue from 20 patients with colorectal cancer and then sequenced genomic DNA isolated from these cultures.

The genetic mutations in the organoid cultures closely matched those in the corresponding tumor biopsies and agreed well with previous large-scale analyses of colorectal cancer mutations.

"These findings confirm that the cultures faithfully capture the genomic features of the tumors from which they are derived as well as much of the genomic diversity associated with colorectal cancer," the authors noted.

To link drug sensitivity to genetic changes, the researchers next screened the responses of the organoids to 83 experimental and approved cancer drugs.

Given their diverse genetic profiles, the organoids displayed a range of sensitivities to the drugs.

"At some point in the future, this approach may be suitable for modeling individual patient response to cancer therapies to inform clinical treatment," Garnett noted.

Moving forward, the researchers plan to develop an organoid biobank for other tumor types.

The study appeared in the journal Cell.

Source: IANS
Font : A-A+



Recommended Readings

Latest Cancer News

Breast Reconstruction and Shorter Radiation: The Winning Combo!
Shorter radiation course is just as good as the regular one for women choosing breast reconstruction after mastectomy, saving time and money.
Innovative Cancer Implant Technology Holds Promise to Cut Death Rates by Half
HAMMR's small size permits minimally invasive implantation, monitoring cancer status, and dynamically adjusting immunotherapy, akin to a glucose monitor.
Personalized Vaccine and T Cell Therapy for Ovarian Cancer Patients
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Kinase-Targeted Therapy Revolutionizes Colorectal Cancer Care
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
Novel Photo-Oxidation Therapy Holds Promise for Anticancer Treatment
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

3D Organoids from Tumors of Cancer Patients May Help Develop Improved Treatments Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests